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CHRONIC OBSTRUCTIVE PULMONARY DISEASE
AND ITS IMPACT ON DENTISTRY 
NAJEEB MAAN FRANGOOL 
ABSTRACT 
The impact of Chronic Obstructive Pulmonary Disorder is material in the 
dentistry field which not only centers its efforts on managing the oral health of the 
afflicted patients, prescribing proper medications, but also on raising awareness 
mainly through dental hygiene and smoking cessation. This literature review will 
explore the status and accomplishments of the field of dentistry with regards to 
battling COPD. The first section of the paper discusses the nature and dynamics of 
the disease which ranks between the third and fourth most common cause of death 
in the United States alone. Certain data trends from 1970 until 2002 showed double 
the death rates caused by the disease, and that exposure to environmental or 
occupational risk factors (e.g. dust, fumes, etc. must be seriously considered for the 
effective management of COPD. 
The pressure of COPD management is great among dental practitioners who 
must ensure the safety of patients by providing the most suitable drug regimen and 
having a well-coordinated dental practice (i.e. with other health practitioners to 
avoid exacerbation of the disease which often leads to hospitalization. The latter is 
often the result of oral devices or materials that are often comprised of small objects 
which might be swallowed or aspirated into the oropharynx of the patient when 
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proper positioning during dental check-ups is not properly performed. Dentists 
must also make sure that they are able to gain the patient’s confidence and to avoid 
patient reluctance during dental care. 
Numbers and statistics also reveal that an estimated 24 million of the 
population in the United States is afflicted by COPD, and that is from 2015 alone. It is 
also prevalent among the male population which has a death rate of 83 per 100,000, 
while the death rate among women is 57 per 100,000. Immediate treatment of 
COPD is also emphasized to prevent hospitalization rates from rising, and as far as 
dental practice is concerned, they are often aware of CODP patients which number 
approximately 130 out of 2000. Smoking cessation is considered the best preventive 
measure in COPD management. Educating patients on the real dangers involved 
with smoking will help encourage them to quit while promoting better oral health. 
 The field of dentistry is constantly responding to the challenges of COPD, and 
significant breakthroughs have already been achieved due to research efforts on 
COPD management. Through professional coordination with other fields in the 
healthcare system, it is with great hope that dental practitioners will contribute 
more to the alleviation of patient conditions and providing improved quality of life.  
 
 viii 
TABLE OF CONTENTS 
 
DEDICATION .................................................................................................................................................. iv 
ACKNOWLEDGMENTS ................................................................................................................................ v 
ABSTRACT ....................................................................................................................................................... vi 
TABLE OF CONTENTS.............................................................................................................................. viii 
LIST OF TABLES ............................................................................................................................................. x 
LIST OF FIGURES...........................................................................................................................................xi 
LIST OF ABBREVIATIONS ....................................................................................................................... xii 
INTRODUCTION.............................................................................................................................................. 1 
Background Information ............................................................................................. 3 
Natural History............................................................................................................ 7 
PUBLISHED STUDIES ................................................................................................................................ 10 
Impact on Dentistry................................................................................................... 14 
How COPD is Affecting Dentistry ........................................................................... 17 
Interdisciplinary Collaboration ................................................................................. 23 
How the Dentist Needs to Adjust to the Patient's Needs .......................................... 23 
DISCUSSION ................................................................................................................................................... 29 
Status of Dentistry on COPD Management .............................................................. 31 
Possible/ Planned Guidelines .................................................................................... 37 
 
 ix 
Dealing with Co-Morbidities (COPD and Oral Diseases) ........................................ 41 
CONCLUSION................................................................................................................................................. 48 
REFERENCES ................................................................................................................................................ 49 



































LIST OF TABLES 
 
Table Title Page 
1 Components Applied in the Screening, Diagnosis, and 
Treatment of COPD 
12 
2 COPD and It is Link to Oral Health.  20 






















Figure Title Page 
1 Trends in age-standardized death rates on six leading 
causes of death 
4 
2 Clinical algorithm for treatment based on Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) 
stage. 
30 



























LIST OF ABBREVIATIONS 
 
AHRQ ......................................................................... Agency for Healthcare Research and Quality 
ARIC .......................................................................................... Atherosclerosis Risk in Communities  
CDC .............................................................................. Centers for Disease Control and Prevention 
COPD ............................................................................... Chronic Obstructive Pulmonary Disorder 
ERS ........................................................................................................... European Respiratory Society  
GOLD .................................................... Global Initiative for Chronic Obstructive Lung Disease 
IoDT ................................................................................................................... Internet of Dental Things 
IoMT ............................................................................................................... Internet of Medical Things 
PFT .....................................................................................................................Pulmonary Function Test 
RCMP ................................................................................................... Royal Canadian Mounted Police 
USPSTF ......................................................................................... US Preventive Services Task Force 







 Chronic Obstructive Pulmonary Disorder or COPD is a disease which is 
characterized by difficulty in breathing due to an obstruction in the person’s lungs 
and airways. Patients rely heavily on treatments in order to alleviate the symptoms. 
It is the fourth leading cause of death globally which affects people’s livelihood as 
their work performance becomes impaired due to the disease. There is currently no 
known cure for this illness which tends to progress over time. In the United 
Kingdom alone, there are more than 1 million COPD confirmed cases that have been 
recorded, while another 2 million remain undiagnosed by their physicians. Smoking 
is considered as the leading cause of COPD. But individuals who are exposed to 
environments like foundries, coal mining, cotton mills, and concrete manufacturing 
are also vulnerable to the disease (Kon, Hansel & Barnes, 2008). 
 COPD is commonly identified with emphysema and chronic bronchitis. Apart 
from this, it is also known as the fourth common cause of death which has an 
estimated 125,000 casualties in the United States alone (Misch, 1999). The 
progressive nature of COPD causes the worsening of one’s pulmonary or lung 
function, which abruptly brings about respiratory failure and finally death. In the 
field of dentistry, managing patients with COPD is particularly challenging which 
requires positioning them in a normal supine position, or sometimes allowing them 
to lie down in a position that will ensure comfort. These are just some of the 
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common procedures performed by dental professionals who make sure that 
individuals with COPD have at least minimal difficulty in breathing exertion which is 
a common risk among these patients (Misch, 1999).  
The goal of the following discussion is to shed light on the nature of COPD 
and its impact on the field of dentistry. This is composed of a literature-based 
research which will cover at least four sections. The first section contains a 
background information on COPD which is a discussion of past and current trends of 
death-related data pertaining to the disease. It is emphasized here that more high-
quality data is needed in order to arrive at more accurate approximations when it 
comes to the figures of COPD deaths on a global basis. The second section will take a 
different turn as the topic explores the impact of COPD on the field of dentistry. This 
talks about measures or procedures that dentists need to consider to make sure that 
they have the necessary adjustments to respond to the patient’s needs. The section 
will also include relevant numbers and statistics to be presented through the use of 
tables and graphs in order to facilitate in-depth analysis on the subject. The third 
section will include important discussions of the field of dentistry and its status, plus 
relevant guidelines detailing plans that will set the standards or determine future 
course of action in the management of COPD. The paper concludes with a discussion 
of the status of dentistry in terms of COPD management which remains a challenge, 
yet is gradually improving due to discoveries made by researchers in terms of its 
nature and predictability. Furthermore, planned guidelines are also constantly 
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provided that will direct both patients and dental practitioners towards a more 
suitable treatment. 
Background Information 
According to Kon, Hansel and Barnes (2008), COPD is a non-reversible and 
progressive lung disease. Albeit preventable and treatable, most patients would 
tend to ignore symptoms which are commonly composed of coughing and exertional 
dyspnea, therefore leading to more complications such as muscle weakness, general 
reduction in vitality and strength of body and mind, cachexia, cardiovascular 
disease, metabolic syndrome, anemia, depression, etc. COPD is considered by the 
World Health Organization (WHO) to be a Global Burden Disease which placed sixth 
in 1990 as the leading cause of death, while it is also anticipated that it may place 
third by the year 2020 (Figure 1). Most data reflecting high COPD cases were taken 
from industrialized countries, however most analysts agree that the leading cause of 
the worsening of COPD worldwide is the increase in cigarette smoking, especially in 
developing countries. Data records reveal that tobacco smoking is more prevalent 
among the male population at 49% and only 8% among women. 
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Figure 1: Trends in age-standardized death rates on six leading causes of 
death (Kon, Hansel & Barnes, 2008) 
Based on Figure 1 provided by Kon, Hansel and Barnes (2008), it is revealed 
that in the age-standardized death rates from all causes in the United States alone, 
COPD appears to have doubled when it comes to death rate between 1970 until 
2002. This only shows that many factors need to be considered especially when it 
comes to people’s exposure to risk factors (e.g. occupational exposures like dusts, 
isocyanate fumes, solvents, viral and bacterial infections during childhood, etc.) as 
well as the effective management of the disease. Furthermore, continuous 




More recently, Lortet-Tieulent et al. (2019) revealed a slight shift in these 
trends, however this time using the global trend. Based on the international analysis 
provided by WHO, COPD death rates have declined in most countries between the 
years 1995 and 2017. However, there was also a corresponding growth in the 
amount of deaths over the past 20 years. This figure was published in the European 
Respiratory Journal concurrently with World COPD Day. This information is already 
inclusive of statistical data from nations that are pending assessment for COPD 
mortality rate. Furthermore, the journal also emphasized necessary measures in 
order to  reduce exposure to risk factors of the disease, namely the strengthening of 
current tobacco control policies as well as declining poverty which are significant in 
promoting a positive effect in the overall reduction of COPD death rates. 
Lortet-Tieulent et al. (2019), a research fellow at the WHO International 
Agency for Research on Cancer stated,  
"According to WHO data, in 2015 there were 175 million people living 
with COPD. The burden of COPD continues to be high, but the existing 
COPD mortality data were based on outdated statistics from a select 
number of high-income countries in Europe, Australia, Japan and the 
USA. There is a need to publish up-to-date estimates and to include 
mortality data from more varied regions of the world in international 
comparisons, as very little is known about the rate of COPD deaths in 
Latin America, Oceania and parts of Europe."  
 
She further suggested that the number of deaths are increasing due to a 
corresponding increase in life expectancy as well as population growth. This data 
indicates that the magnitude or extent of COPD patients who lose their battle to the 
disease is diminishing overall which is considered as a positive sign because it 
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further entails lesser exposure to COPD risk factors and better management of the 
disease. 
This was also confirmed by researchers who proclaimed that the lessened 
exposure to risk factors like tobacco smoking, air pollution in both home and work 
settings, decreased poverty levels, and better quality in terms of access to 
healthcare in most countries hold a significant role in the decreasing number COPD 
mortality rates. However, an in-depth analysis by sex from 2016 data showed an 
uptake of smoking among women over the past generations (Lortet-Tieulent et al., 
2019 . It was also found that in nations where the female population has been 
smoking as much and for as long as the male groups such as the U.S., the female 
COPD death rate is already the same to that of men. But researchers were advised 
against the tendency to overstate the rising death rates in women, where one 
assessment made in most of the 24 countries revealed that COPD mortality 
remained twice as eminent in men when compared with women. This implies how 
some data likely underestimates the true mortality burden of COPD. Furthermore, 
more high-quality data from low-income countries is needed to provide more 
accurate estimates of global COPD deaths, as well as to find more effective 







 According to Viegi et al. (2007), COPD patients often complain about chronic 
cough, phlegm, or difficulty in breathing. Its natural history varies among 
individuals which is why the latter also have different clinical courses over time. 
Another indication is the rapid decline in lung function, while others show a 
gradually, roughly ‘‘stable’’ decline. The progression of COPD may be arrested 
through non-exposure to noxious elements as well as regular treatments to curb 
symptoms, otherwise it reaches a point where it already becomes curable. Studies 
also reveal that end-stage COPD patients have multiple comorbidities, or the 
coexistence of two or more related medical conditions (e.g. hypertension, ischemic 
heart disease, diabetes, etc.), which are connected with the advancement in aging as 
well as the common underlying risk factor of smoking. 
 However, the ultimate symptom of end-age COPD is exacerbated dyspnea 
with an already limited physical performance during exercise, activities of daily 
living, and ultimately even at rest. In addition, other physical struggles endured by 
patients include cough, retained secretions, pain, fatigue, weakness, weight loss, 
delirium, poor sleep quality (Viegi et al., 2007). Poor sleep quality, particularly 
obstructive sleep apnea syndrome, is very common among COPD patients that are 
obese. As a consequence of the airflow blockage, the sleeping patient is often 
struggling to enhance the air inflow rate so that the required oxygen may be 
supplied. However, this also leads to loud, often intense and increasing snoring, 
hence disrupting the patient’s sleep with partial or complete awakening. 
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Furthermore, the patients also have to deal with temporary loss of strength and 
energy as they are often drowsy during daytime, along with the psychomotor effects 
that are contingent on the extremeness of hypoxemia and the length of drowsiness 
(Tsvetanov, 2016). 
During the process of dental exploration, methods of examination involving 
muscle firmness or location in the head and neck is showed as a means of 
distinguishing if there are existing masses or tumors which are inducing airway 
obstruction. Certain conditions that also seen to worsen the problem are  
“deviation of the nasal septum, class II malocclusion, large gonial 
angles, the physical magnitude of the tongue and its base, and the 
oropharynx (size of the uvula, size and features of the soft palate 
tissues)” (Tsvetanov, 2016, p. 24).  
 
Because of this, dental professionals are often concerned with patient management, 
and it becomes imperative to make use of suitable oral devices that are designed to 
advance the mandible along with the application of anterior and inferior mandibular 
traction (Tsvetanov, 2016). 
There are also emotional factors such as anxiety, panic, and depression 
which lead to the patient’s poor quality of life. These could all be avoided but 
unfortunately, the lack of COPD awareness among patients and health workers 
causes underestimation on the seriousness of the disease. For instance, a Spanish 
telephone survey of 6,758 respondents showed that only 45% had undergone 
spirometry which measures the patient’s vital capacity, promises early detection, 
and is often requested by pulmonologists (Viegi et al., 2007). Unfortunately, high-
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quality spirometry is said to be underutilized by clinicians due to lack of familiarity 
and encouragement as to its use. 
 Some evidence that the disease has been underestimated and, therefore, its 
prevalence appear in an international survey.  There are a high proportion of people 
whose basic daily life activities were restricted by the disease, including frequent 
absence from work, and healthcare use on a regular basis. Basically, what is being 
missed here is the additional number of patients with end-stage COPD as related to 
the major goal in preventing the natural progression of the disease. Long-term 
oxygen therapy and assisted ventilation may be helpful in managing the disease but 
the elevated suffering for the patients and their families serve as a huge burden for 
the society as well as the economy. For example, in 2001, the ERS European Lung 
White Book provided that the overall annual cost for COPD in Europe reached 38.7 
billion euros which consisted of 4.7 billion in ambulatory care, J2.7 billion for drugs, 
J2.9 billion for inpatient care and 28.4 billion for lost work days (Viegi et al., 2007).  
Some recommended ways in easing the burden of COPD is through risk 
reduction, particularly stopping smoking as well as the avoidance of cumulative 
individual exposure to other elements which put an individual at risk such as indoor 
and outdoor air pollution. Smoking cessation strategies are deemed as cost-
effective, and even more beneficial when accompanied by other measures like 
optimizing identification, documentation, and treatment of every tobacco user that 





 Mirza et al. (2018) also described COPD as common, preventable, and 
treatable based on the definition of the Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) which was established in 1998 by the National Heart, Lung, 
and Blood Institute. GOLD emphasized that COPD now ranks third as the leading 
cause of death in the United States. Therefore, it emphasizes the importance of 
diagnosis which is composed of the following features, namely: a post-
bronchodilator forced expiratory volume in 1 second or FEV1/forced vital capacity 
(FVC) ratio of less than 0.70, which “confirms the presence of persistent airflow 
limitation” and assess the patient’s pulmonary function. This is followed by the 
assessment of “appropriate symptoms” which often includes dyspnea or troubled 
breathing, chronic cough, sputum production, or wheezing. Lastly, there is the 
consideration of “significant exposures to noxious stimuli” which includes history of 
smoking cigarettes and other environmental elements to name a few. 
 It is also imperative to conduct a more detailed evaluation of COPD which 
includes the appraisal of pulmonary mechanics through full lung function tests. 
There is also the determination of lung structure which is commonly acquired 
through advanced imaging. Another important consideration is existing 
comorbidities of COPD such as ischemic heart disease or diabetes. This is 
particularly crucial when symptoms are not in agreement with physiological 
measures of disease severity, since there are health conditions that may imitate 
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COPD. This information is important especially when it comes to treatment which 
puts more emphasis on symptom burden and exacerbation, rather than airflow 
obstruction. Other items for consideration are the patient’s clinical profile, drug 
availability, cost, patient preference, and familiarity with delivery device (Mirza et 
al., 2018). 
 However, Mannino and Thomashow (2020) advise against the full reliance 
on COPD screening of asymptomatic persons. This is based on the findings of the US 
Preventive Services Task Force or USPSTF in 2016 which provided the argument 
that there is no proof that such procedure leads to better health-related quality of 
life, morbidity or mortality, nor does early detection of the disease change its course 
or improved patient condition. The reason behind this position is that there is only 
one recognized intervention deemed to change the natural history of COPD and that 
is smoking cessation. Smoking cessation is generally looked at as the best step in 
managing or preventing the excess risk of many ailments. Therefore, based on this 
argument, there is no fundamental logic behind the screening for COPD especially 
when a person does not show symptoms. Therefore, in connection to the former, it 
appears that neither spirometry nor other screening tools such as questionnaires or 
criteria (one example is provided below), is capable of giving the desired health 







Table 1: Components Applied in the Screening, Diagnosis, and Treatment of 




 If we begin analyzing the table, one may easily find that it does not justify the 
rationale for COPD screening. Although the features provided such description as 
the patient’s physiologic parameter of airflow obstruction, the authors argue that 
the causes of this physiologic abnormality can arise from a number of different 
processes. Other irregularities that may also exist are large airways, small airways, 
alveoli, and the pulmonary vasculature. In other words, the screening process does 
not serve well the management of the disease since it is already being assessed at 
the level where physiologic impairment is not only present, but COPD  is already 
deeply rooted. Hence, the disease is already on its advanced stage with very little 
chance of remedy (Mannino & Thomashow, 2020). 
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On the other hand, Sekine et al. (2012, highly recommend COPD screening 
for disease prevention especially among habitual smokers. Furthermore, they 
strongly advise early screening so that smoking can be stopped immediately. In 
addition, comorbid ailments like lung cancer (which often develops among 
individuals with COPD, coronary artery disease, congestive heart 
disease, other cardiovascular diseases, and even neurological diseases will also be 
identified so that suitable programs may be distinguished for struggling patients. 
For instance, individuals who are at high risk for developing lung cancer are deemed 
as suitable candidates for early screening surveillance and preventive intervention. 
Through the use of a risk prediction model for smoking, the duration of the latter 
will serve as basis in predicting the COPD progression. 
Researchers believe that COPD may either be under-diagnosed or 
misdiagnosed, hence its prevalence. They also revealed that an approximated 72% 
to 93% of COPD patients were not properly diagnosed. Furthermore, this also 
confirms previous findings that spirometry is only utilized for only thirty percent to 
fifty percent of new cases. COPD in the general population is estimated at one 
percent, with prevalence increase from eight percent to ten percent of the 
population over forty years of age. These figures may also rise with the increase in 
age or at 60 years and older, which is at 5.8% at 50 to 59 years, 15.7% at 60 to 69 
years, and 24.7% at 70 years and older. This is why an early diagnosis or screening 
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of COPD is recommended when it comes to high-risk patients, particularly with the 
utilization of spirometry which has been proven to be crucial in this process. This is 
because there have been existing accounts that spirometry is capable of establishing 
airflow obstruction in 18% of individuals with respiratory symptoms, as well as in 
four percent of those without symptoms (Sekine et al., 2012). 
 Sekine et al. (2012) also stress out issues of limited screening to individuals 
aging sixty years or older with smoking history. They emphasized that none-
smokers or those younger than sixty years old should also be considered, especially 
since there has been a reported increase in lung cancer among nonsmoking females, 
which is mostly confined to elderly females. In relation to this, it is also proposed 
that implementing screening for COPD (albeit challenging in primary care settings) 
as well as case findings are considered to be a suitable approach. Hence, cases that 
concern individuals younger than sixty years, with a positive smoking history and 
chronic cough, must undergo pulmonary function testing for COPD screening to 
guarantee disease management (Sekine et al., 2012). 
Impact on Dentistry 
 COPD leads to patient suffering and also implicates routine dental care. In a 
study published in the British Dental Journal, Devlin (2014) described how dental 
professionals are affected by the disease’s management, particularly when it comes 
to symptoms of candida infection and dry mouth. Dental treatment of patients with 
COPD involves making sure that they are seated upright in the dental chair since 
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horizontal position will cause trouble in their breathing. Dentists also exercise 
caution in making sure that periodontal (deals with diseases of the gums and other 
structures around the teeth) bacteria is not being transmitted to the lungs and cause 
respiratory infections, hence emphasizing the urgency of oral hygiene as well as 
smoking cessation which is facilitated by programs like nicotine replacement 
therapy and pulmonary rehabilitation. It is important to note that it is the 
responsibility of the dentist to promote a non-smoking habit regimen to their 
patients. But another issue is the patients’ non-attendance of non-participation in 
programs and dental practice appointments due to claims like lack of available 
transport which is crucial to those who are socially isolated and living alone. In 
addition, those who are afflicted by severe disease have poor mobility, dyspnea and 
frequent hospitalization which make regular dental attendance difficult. 
 It is important to note that treatment is not advisable with dental patients 
suffering from severe or unstable COPD especially when performing dental hygiene. 
This will either require a rescheduling of the routine appointment or a referral for 
medical attention if the following signs would occur in the client, namely: acute 
respiratory tract infection, shortness of breath at rest, productive cough, and an 
oxygen saturation of less than 91% by pulse oximetry. In case of a likely respiratory 
fatigue or failure, emergency protocol is essential followed by immediate transfer to 




 COPD leaves both oral and dental impact. Its relevance to the dentist includes 
providing a suitable drug regimen in treating patients through the course of clinical 
dental practice in order to avoid exacerbating the symptoms of dental diseases like 
dry mouth, oral candidiasis, and even gastro-esophageal reflux disease which has 
been associated with COPD. Most of the individuals undergoing dental surgery for 
routine treatment are composed of elderly patients who are often suffering from 
respiratory illness thus dentists often inquire about chronic production of sputum 
within a period of at least 3 months a year for 2 successive years. Furthermore, 
emphysema is also being monitored which leads to the alveoli of the lungs being 
damaged and enlarged due to long periods of cigarette smoking. Dental treatment in 
an upright position creates a corrective effect with the accessory muscles of 
respiration deemed as more effective. On the other hand, the process of providing 
oxygen to blood may be reduced when patients with advanced COPD are placed in a 
supine position. This is because the chest and neck muscles are used to assist in the 
respiratory effort which makes restorative dentistry and patient breathing difficult 
(Devlin, 2014). 
 Devlin (2014) also discussed the limited options when it comes to 
pharmacological treatment, except for the inhaled short-acting beta agonists like 
salbutamol which is ingested before dental treatment to aid breathing. There is also 
the long acting beta agonists, inhaled steroids, and inhaled long acting muscarinic 
antagonists with the purpose of dilating the bronchi and decreasing airway 
inflammation. Other prescriptions also include inhaled corticosteroids for COPD 
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patients suffering from severe to very severe airflow obstruction, particularly when 
exacerbated or persistent breathlessness is present. However, too much intake of 
the latter may lead to increased risk of non-fatal pneumonia and oropharyngeal 
candidiasis. Candidal infection may also affect elderly people wearing complete 
dentures as well as patients who have undergone repeated courses of antibiotics. 
Patients who also take steroid-containing inhalers should rinse their mouth after 
usage. The underlying side effects of routine pharmacological management and 
good periodontal helps the prevention of both infective and non-infective COPD 
exacerbations. This is why the physician and dentist must coordinate in providing a 
holistic approach to treatment, hence improving the patients’ quality of life. 
How COPD is Affecting Dentistry 
 Lozano, Pérez and Esteve (2011) provides a deeper understanding of the 
challenges that respiratory disorders like COPD place on dental professionals in 
terms of additional or special care for affected patients based on their diagnosis. 
COPD calls for special measures in order to prevent other complications like lung 
infections secondary to the aspiration of microorganisms in the presence of 
deficient periodontal conditions, oral disorders like xerostomia, oropharyngeal 
candidiasis, gingivitis, tuberculosis (albeit infrequent), etc. These conditions may 
directly implicate the dental professional in the management of such patients, 
particularly during the process of preparing and fitting oral devices. 
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Dentists often deals with issues regarding patient management and safety, 
while also making sure that patients have access to effective treatments. This is 
especially important for patients with COPD during the preparation and fitting of 
oral devices with the main purpose of advancing the mandible, as well as applying 
anterior and inferior mandibular grip. Furthermore, dentists also handle the crucial 
work of making sure that small objects or elements will not be swallowed or 
aspirated into the oropharynx when the patient is in the supine or semi-raised 
position. Once foreign bodies are exposed to the saliva, it would be difficult to 
control the objects which, if swallowed, may either serve as minimum risk or 
potentially fatal depending on their size, shape, and flexibility. They also include 
dental materials with powder ingredients like alginate or powdered gloves which 
must be utilized to a minimal degree since these may cause airway obstruction 
(College of Dental Hygienists of Ontario, 2015). 
 Dental professionals must also prevent oral micro-organisms from reaching 
the respiratory tract leading to infection. One route of disease transmission is 
hematogenous spread of bacteria which often occurs in some dental and 
prophylactic procedures. However, this type of infection is not widely distributed, 
with only two well-documented case reports provided (Mojon, 2002).These are 
common scenarios that compel the field of dentistry to raise awareness about the 
impacts of poor oral hygiene. The related plaque buildup on the teeth or dentures, 
as well as some periodontal diseases may exacerbate the condition of COPD 
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patients. The same goes with efforts on oral cessation which is also accompanied by 
challenges like obtaining accurate smoking history for the elderly (Mojon, 2002). 
 Inserro (2018) provided that a small observational study indicated that some 
people suffering from COPD are often shown to have poor dental habits as well as 
oral health issues. Their history also indicates that they have more experience of 
dental infections, tooth extractions with high prevalence as well as denture, and 
fewer teeth resulting from plaque buildup and other dental damages. This 
information was used in correlating the percentage of days with patient coughing or 
sputum production. 
Scannapieco, Bush, and Paju (2003) demonstrates the link between COPD 
and oral health, particularly the exacerbation of the patient’s condition (Table 2). 
Included in this study is the analysis of 23,808 respondents with the confirmation of 
the National Examination Survey I or NHANES I. It also reinforces that poor oral 
hygiene and smoking were statistically connected with chronic respiratory disease. 
Furthermore, it also revealed that periodontal disease which is assessed through 
alveolar bone loss shown by periapical radiographs is an independent risk factor of 
COPD among adult males. This is based on the VA Normative Aging Study. 
Furthermore, a 30-year follow-up of the respondents attempted to disclose the risk 
of developing COPD. The latter was made using spirometry where it was found that 
279 out of 1,112 subjects developed COPD and that they have the worst periodontal 





























































Based on the above findings, it is clear that dental practitioners must consider the 
serious effects of respiratory pathogens invading the oral region as this may lead to 
lung infection of highly vulnerable subjects. With proper intervention and improved 
oral hygiene, lessened oral inflammation may decrease the occurrence of lung 
infection. Further research involving oral health variables are also needed in order 
to confirm this impact of oral health (Scannapieco, Bush, & Paju, 2003). In 
connection with this, Stefanac and Nesbit (2006) provided that simple rules alone 
are not enough in the delivery of dental care, since every dentist is expected to be 
knowledgeable of any necessary treatment modifications in managing patients. It 
becomes more challenging when patients have special needs which would require 
the dental team to undertake unusual delivery of dental treatments. 
COPD affects the dentistry field by the added pressure that is placed on 
dental professionals. The consistent focus which is demanded from the dental team 
is a way of ensuring a complete range of preventive services and relevant support. 
The patient’s optimal care should be compatible with their dental treatment goals 
which may range to complete oral rehabilitation   (Stefanac and Nesbit, 2006). Pyle 
and Stoller (2003), for instance, provided their research on geriatric dentistry, 
particularly the responses needed for this aging patient group suffering from 
chronic medical conditions. The field of dentistry needs greater interdisciplinary 
training based on historical policy recommendations in education, curriculum 
implications for dentistry, and strategies. 
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Since there is a discrepancy between past educational recommendations and 
current approaches, the field of dentistry is compelled to come up with new models 
of curricula that will facilitate coordination with medicine and allied health 
professions in managing chronic illnesses like COPD. Doing so will provide better 
understanding regarding the medical/dental complexities of COPD patients. On the 
other hand, the professional and ethical obligations of dentistry to society are also 
emphasized, given that there are dental professionals who are unwilling to serve 
Medicaid patients. Therefore, Pyle and Stoller (2003) indicated how this challenge 
affects dentistry, and how it must incorporate service learning programs to promote 
institutional value systems that will help maintain professional and ethical 
obligations. 
Stahl, Meskin and Brown (2004) also added the need for providing standard 
case definitions. For example, the Division of Oral Health at the Centers for Disease 
Control and Prevention or CDC, together with the American Academy of 
Periodontology assigned a working group to define severe and moderate 
periodontitis. Other succeeding efforts also involved the addition of a subcategory 
for determining gingival conditions, recognition of subtypes of periodontitis, and the 
clarification of periodontitis as the manifestation of systemic disease. Also in 2014, a 
task force was assigned to establish clinical interpretation of this classification 
which emphasized the importance of attachment levels in the diagnosis of 
periodontitis. This also paved the way for properly identifying the difficulties 
involved in the accurate measurement and interpretation of non-inflammatory gum 
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recession. The proper interpretation between localized and generalized 
periodontitis provided the criteria that is widely adopted in the USA today. 
Interdisciplinary Collaboration 
 In order to make sure that the field of dentistry is able to respond to the 
challenges of COPD, it must ascertain that the foundation of dental education is 
responsive to the important elements, namely: changing population demographics, 
disease patterns, and health care delivery. This is also a way of getting rid of dental 
health disparities affecting especially older dental patients as a result of non-
existent good research data. Furthermore, oral health disparities will be lessened by 
cooperative research from the basic science, clinical science, demography, and social 
science (Pyle & Stoller, 2003). 
How the Dentist Needs to Adjust to the Patient's Needs 
 The dentist’s role is critical in the management of patients suffering from 
COPD. It is also imperative that patients are comfortable working with them.  in 
order to gain their trust easily. Childhood experiences tend to impact one’s attitude 
towards dentists who are often seen as either powerful or dangerous. Dentists must 
be able to address such unrealistic expectations, as well as any misplaced feelings or 
attitudes that may impede his/her relationship with the patient. In this way, any 
negative emotions such as anxiety during dental treatment may be dealt with as 
early as possible. An Australian study provided that patients’ perceptions are strong 
predictors of dental fear as well as negative dental experiences. These may lead to 
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unfavorable incidents such as pain during dental injections, thus the possible 
avoidance of dental care (Little et al., 2017). 
 In such cases, particularly when the patient’s breathing is affected following 
procedures like the aspiration of foreign bodies, dentists are expected to apply vital 
support measures that involve airway permeation through a cricothyroidotomy, a 
kind of procedure that involves tracheotomy by incision through the skin as well as 
the cricothyroid membrane. This is performed to provide relief to an obstructed 
airway, otherwise the swallowed object should still be recovered in order to calm 
the patient. COPD may potentially lead to the dental patient’s worsening respiratory 
condition during the course of dental treatment, thus stressing the need for 
precautions. As already mentioned, one of the adjustments which dentists need to 
perform is to treat the patient in the vertical position (Lozano, Pérez & Esteve, 
2011). 
Dental chair adjustments are crucial in avoiding breathing compromise, 
hence it is recommended that patients be placed in semi-supine or upright chair 
positions, as well as making the appointment shorter because some patients may 
not endure prolonged sitting in the dental chair (College of Dental Hygienists of 
Ontario, 2015). Rubber dams, or the thin sheet of rubber stretched around a tooth to 
keep it dry during dental work, should also be used when the patient suddenly 
complains of a suffocating sensation (Lozano, Pérez & Esteve, 2011). In some cases, 
it may be challenging to use a rubber dam especially when patients are identified as 
mouth breathers, hence unable to tolerate additional obstruction. Dental patients 
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with COPD are also most benefitted when treated at midmorning or in the early 
afternoon to avoid becoming increasingly dyspneic especially when laid supine 
(Scully & Ettinger, 2007). 
 Rahman et al. (2011) explains that dental health care professionals must 
obtain an in-depth understanding of COPD for the successful treatment of patients, 
especially since the treatment of medically compromised individuals often involves 
stressful dental procedures that puts COPD patients at special risk.. Therefore, 
sufficient knowledge of dental management protocol, especially for COPD patients 
belonging to economically deprived groups, is critical. Also, their main goal, 
especially that of a dental surgeon, is to properly manage a patient with existing 
medical condition to prevent the occurrence of disorder during the course of 
another disease as a result of dental treatment. In the field of dentistry, this is 
considered as a primary fear. Therefore, as another form of adjustment to the needs 
of COPD patients, it is recommended that dental health practitioners develop a risk 
assessment to determine which approach is suitable for the patient. The first step is 
having a comprehensive knowledge of the patient's medical history which can be 
obtained through health history questionnaire. Another is through a comprehensive 
interview by the dental surgeon which will serve as basis of the risk assessment 
process. 
Dentists must also be conscious about their patient’s emotional or mental 
state which has an impact in the assessment of respiratory function. They must 
ensure that stress levels are reduced, or avoid procedures that may depress a 
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patient's respiratory function in the management of patients with moderate to 
severe chronic obstructive pulmonary disease. It would also be helpful if patients 
are provided with a professional and reassuring environment which includes short 
but focused dental treatments. Dental surgeons are also expected to provide for the 
patient's respiratory reserve as well as to determine his tolerance for general 
anesthesia. This also includes the basic knowledge that outpatient general 
anesthesia is not advisable for most patients with COPD. Adjusting with them 
emphasizes that dental practitioners are well equipped to provide care especially 
when patients have complex medical conditions. In addition, sufficient knowledge 
on pulmonary diseases as well as their signs, symptoms and management of an 
emergent episode associated with COPD will enable a routine dental care which will 
guarantee patient safety (Rahman et al., 2011). 
 
 In line with this goal, Scully and Ettinger (2007) provided at least three 
classifications of patients with COPD in determining the type of dental care that 
needs to be administered, namely: low, moderate, or high risk patients:  Patients 
who are classified as low risk experience dyspnea on effort, however are able to 
maintain normal blood gas levels. Therefore, patients under this category may 
receive a full range of dental treatment with minor modifications. Patients who are 
at moderate risk also experience dyspnea on effort, however are treated on a long-
term basis with bronchodilators or, in a more recent development, with 
corticosteroids and partial pressure of oxygen or PaO2. Medical consultation is 
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crucial to uncover the level of control of the disease before beginning any dental 
treatment. Last but not the least, those patients at high risk are known to have 
symptomatic COPD that is undiagnosed and untreated. A medical consultation is 
strongly advised before any dental treatment is performed. This will help the proper 
handling of any underlying dental issues. 
 
  Such consideration given to dental patients is critical given the fact that their 
oral health is an important factor in determining the state of respiratory diseases 
such as chronic obstructive pulmonary disorder. When patients are made to feel 
that their dentists are concerned and willing to accommodate them, they are also 
more likely to participate in routine oral checkups or treatments. As a result, oral 
hygiene becomes improved and lower respiratory issues decline. For instance, 
Japanese nursing home residents have been known for their decreased pneumonia 
due to regular oral care. Another is the utilization of chlorhexidine swabs in 
intubated and mechanically ventilated intensive care unit patients which was 
reported to decrease the rate of ventilator linked to pneumonia. On the other hand, 
a small, randomized controlled study participated in by sixty patients with COPD 
demonstrated that regular tooth scaling and root planning diminished percentage of 




This is why the public must not discount the fact that COPD does result from 
factors involving poor dental hygiene practices as well as history of dental 
infections. Poor overall oral health is related to poor quality of life and the daily 
burden of respiratory symptoms such as breathlessness, wheeze, cough, and sputum 
production that are known to cause airflow obstruction and inflammation, thus 














 COPD is a serious ailment that is expected to affect more than 24 million 
people in the United States alone. An estimated 8% of adults and 14% of older 
adults in the United States are affected by the disease which is more prevalent in the 
male population, with a corresponding death rate of 83 per 100,000. On the other 
hand, the death rate for women is 57 per 100,000, aside from the fact that it is 
second only to arthritis as the leading cause of long-term disability and functional 
impairment, therefore affecting one’s quality of living. When individuals with COPD 
are not treated immediately, incidence and hospitalization rates are expected to rise 
with age which is the same for the male and female population. With these, the 
average dental practice of 2,000 patients is approximated at 130 patients who 
exhibit signs of COPD (Figure 2) (Pocket Dentistry, 2015). 
Figure 2  demonstrates the function of smoking cessation, influenza and 
pneumococcal vaccinations, and short- and long-acting bronchodilators in the 
management of COPD includes . Prevention is better than cure that is why it is 
important to place more emphasis on the role of smoking tobacco in the 
management of COPD. With this is mind, dental health care providers are able to 
provide more effective disease management of patients with COPD if the latter are 
encouraged to quit smoking. This is done by providing comprehensive information 
on the diseases, particularly when linked to smoking which allows patients to 
consider the real dangers involved, hence giving up the habit. Interventional 
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strategies like nicotine replacement or bupropion therapy are also beneficial, and 
dental health providers must assist patients in choosing and carrying out any 
suitable the method which is deemed to provide enhanced physical well-being or 







Figure 2: Clinical algorithm for treatment based on Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) stages (Pocket Dentistry, 2015). 
  
 The study conducted by Bergström et al. (2013), showed that smoking 
increases chronic airflow limitation especially among individuals who are 
susceptible to tobacco smoke. In addition, smoking also causes periodontal disease 
among majority of the smokers. However, more study is needed on the subject due 
to certain indications that there were pathologic processes in the mouth cavity that 
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is weakly co-varied with pathological processes in the lungs (emphysema and 
impaired diffusion capacity). This leads researchers to believe that one’s proneness 
to the harmful effects of smoking is not a common feature of an individual smoker as 
the association between chronic airflow limitation and periodontitis tangibly varied 
among smokers. This may also be affected by a person’s age, such that when a 
smoker or non-smoker is above 20 years old, he or she may still be too young to 
develop COPD. 
 
Status of Dentistry on COPD Management 
 Salagare and Prasad (2020) expressed their confidence in the continued 
strength of the dentistry field in countering the society burden of COPD. For 
instance, one revolutionary approach is the Internet of Medical Things or IoMT, a 
technology that maximizes the use of advance devices in the medical field through 
cloud technology, new-generation smart phones, and tablets with integrated apps to 
name a few. These have enabled dental patients to continuously monitor their 
symptoms, hence allowing the field of dentistry to evolve through up-to-date 
computer-based advanced technologies. Furthermore, new preventive disease 
measures and improved diagnostic techniques in last few years also became 
significant with an innovative approach referred to as Internet of Dental Things or 
IoDT which is an application of IoMT in dentistry. 
The main objective of IoDT is the prevention and management of dental 
caries, periodontal diseases, oral cancers, and other dental diseases that leads to the 
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exacerbation of COPD. Its role in collection and monitoring of patients’ data for oral 
health care is of absolute importance especially in terms of eventual risk assessment 
and further research. IoDT technology is considered as a helpful oral heath-care 
model as well as architecture applied with the rising digital progressions in the 
advanced clinical dentistry. Similar technological improvements in the field of 
dentistry will ensure positive impact in clinical monitoring, oral-health data 
collection, and more importantly improve overall management of oral diseases for 
patients with COPD (Salagare & Prasad, 2020). 
Vaderhobli (2011) also provided an insight as to the current status of 
dentistry through his discussion on the advancement of materials for the 
rehabilitation of tooth structures. A precision medicine, referred to as sealant for 
dental coating, is a material which has undergone improvement in order to provide 
added convenience for both dental patients and practitioners. Furthermore, sealants 
are used in the ongoing research efforts in COPD to determine how patients would 
react to several improvements made in these materials. Dentists are constantly on 
the lookout for effective restorative procedures as the main objective of clinical and 
material scientists. Dental materials in this case are used in the oral cavity and must 
meet the satisfactory requirements of similar tooth structures in terms of physical 
and mechanical properties. 
 Shen et al. (2020) provided promising research demonstrating the current 
status of dentistry, particularly by means of periodontal treatment. Periodontal 
disease refers to a disorder that affects the soft tissue around the teeth, such as 
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gingivitis and periodontitis. This is caused by a bacterial biofilm that gathers on the 
teeth, and may even be caused by certain genetic and environmental factors. There 
are studies that prove a link between COPD and periodontal diseases. One such 
study is from Taiwan that showed how patients with COPD are 1.2 times more likely 
than the general population to acquire periodontal diseases. This is because dental 
plaque buildup and hematogenous dissemination of inflammatory mediators, 
making the mouth an important source for potential respiratory pathogens. 
 Zhou et al. (2011) are convinced of the strong link between poor periodontal 
health, as made apparent by more missing teeth and high plaque index, and lower 
quality of life among COPD patients. These patients tend to suffer from different 
levels of disability in their everyday lives which is why dental practitioners must 
ensure that they are providing suitable treatment plans that will guarantee wellness 
both in the physiological and functional state of patients. Kaptein et al. (2008) 
expressed the significance of this illness is being perceived by patients, particularly 
its impact on the latter’s coping behaviors. This is also beneficial for dentistry when 
it comes to identifying how useful integrating illness perceptions are into clinical 
COPD management. 
 Perceptual and behavioral factors of patients with respect to COPD 
conditions are important to dental practitioners in identifying suitable treatments 
that will improve the formers’ quality of life. Refusing to acknowledge them can lead 
to lower patient satisfaction as well as poor medical outcomes. The ideas, views, and 
beliefs of a patient about illness are not only influenced by physicians but as well as 
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the media, friends, parents, the Internet, and even fellow patients regardless if the 
information from them is reliable or not. Nevertheless, these perceptions strongly 
affect the patient’s quality of life, his faithful following of treatment schedules, 
medication use, or the need for future hospitalization even after controlling for 
duration and severity of COPD (Kaptein et al., 2008). 
 The same relevance also applies to dental practitioners whose perceptions of 
their patient’s illness will dictate their decision making in terms of medical 
management, but of course with the proper guidance of their medical expertise, 
accounts of symptoms, and experiences. Dentists must be cautious of arriving at 
unrealistic prognoses of COPD patients, particularly when it comes to the hospital 
admission or non-admission of COPD patients to the Intensive Care unit. The only 
point is that these patient and dentist perceptions will aid in the proper 
identification of intervention opportunities that will properly target the 
achievement of one’s quality of well-being (Kaptein et al., 2008). 
 So what is some of the reliable information regarding the nature and 
dynamics of COPD in connection with dental health? It has been known how COPD, 
as a type of systemic inflammation, involves oxidative  stress that is triggered by 
circulating inflammatory cells as well as increased inflammatory cytokines, or any 
protein molecules secreted by cells of the immune system that serve to regulate the 
immune system. On the other hand, periodontal diseases also involves systemic 
inflammation caused by immune and inflammatory responses to oral pathogens, 
hence describing how periodontal diseases could lead to the development of COPD. 
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Therefore, using the National Health Insurance claims data of Taiwan, around 5,562 
COPD patients with periodontal diseases were identified who have undergone 
periodontal treatment. They were classified as the treatment group. On the other 
hand, the comparison group was chosen by 1:1 ratio which corresponded to the 
tendency score approximated with factors of age, sex, date of COPD diagnosis and 
periodontal treatment, and comorbidities (Shen et al., 2020). 
Both treatment group and comparison groups were followed through after 5 
years with the purpose of forming the basis of risks regarding acute exacerbation, 
pneumonia, and acute respiratory failure. Results showed that the treatment group 
has incidence rates of adverse respiratory events that were significantly lower 
compared to the comparison group, or 3.79 versus 4.21 per 100 person-years for 
emergency room visits, 2.75 versus 3.65 per 100 person-years for hospitalizations, 
and 0.66 versus 0.75 per 100 person-years for intensive care unit admissions(Shen 
et al., 2020). Furthermore, the treatment group also showed 37% reduced risk of 
deaths or 1.81 versus 2.87 per 100 person-years, including an adjusted hazard ratio 
of 0.57 or 95% confidence interval 0.52–0.62. Therefore, it is implied that 
periodontal treatment contributes to the lower risk of adverse respiratory events in 
COPD population of Taiwan, a favorable finding that affirms the good status of the 
dentistry field. This is evidence by the factors like the lessened use of emergency 
services, hospitalization, and ICU admission, and further reduction in mortality rates 
(Shen et al., 2020). 
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Other promising developments in the field of dentistry include research 
conducted by the team from the Tokyo Medical and Dental University. An article by 
Karasuyama (2019) discussed new breakthroughs in the future of COPD 
management using mouse models. According to this research, important element 
that show how mice immune cells, referred to as basophils, causes a stir in the 
rushing down of certain immune responses that cause the airway degeneration that 
is similar to the features of human chronic obstructive pulmonary disorder. This is 
more good news for the dentistry field considering that COPD, as a condition 
affecting the airways and lungs, often baffles dental professionals, thus hindering 
treatment. 
The study was considered as a turning point which was published in the 
journal Proceedings of the National Academy of Sciences USA. Using different mouse 
models, the research team provided comprehensive details of the developmental 
process regarding COPD. Aside from this, they also demonstrated how the immune 
cells basophils, which are formerly believed to be primarily responsible in 
defending against parasitic infections as well as inciting allergic responses, also 
promotes the destruction of alveolar walls. Karasuyama (2019, p. 1) further stated,  
“Our results are surprising because basophils have not previously 
been identified to be active in this kind of situation. It may be that 
basophils were previously overlooked because they only make up 




Because of this discovery, the team, as well as the entire field of dentistry, are 
hoping that more treatments will be created that will at least slow down the 
progression of COPD (Karasuyama, 2019). 
 
Possible/ Planned Guidelines 
 The United States Veterans Health Services and Research Administration 
(1990) provided a detailed plan explaining a suitable set of standards that will 
determine the course of action for dental professionals in managing COPD patients. 
Comprising this guideline is the awareness of the nature of COPD which is basically 
a spectrum containing three main diseases, namely: chronic bronchitis, emphysema, 
and chronic bronchiectasis. It is also important to know that chronic asthma may 
easily lead to COPD, and patients with moderate to severe airway obstruction may 
predict the development of the disease. Therefore, this calls for dental treatment 
that focuses on early intervention in order to achieve optimal oral health for COPD 
patients who are at lower risk. What comes next should be a preventive program 
that is meant to aid the maintenance of oral health especially during the worsening 
of the patient’s pulmonary condition. 
 Another important step is for dentists to determine their patient’s status 
while walking or at rest which would reveal the extent of respiratory impairment. 
Prior to starting dental care, clinicians should determine if the patient’s respiratory 
disease is severe, as well as the degree to which it can be managed. If the patient 
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shows shortness of breath at rest during routine dental care, together with a 
productive cough, upper respiratory infection, or an oxygen saturation level less 
than 91% as shown via pulse oximetry, then the patient is considered unstable 
(College of Dental Hygienists of Ontario, 2015). The following conditions may 
indicate that the patient’s respiratory is in danger: cyanosis of the extremities, 
secondary polycythemia, dyspnea both at rest and exertion, orthopnea, use of 
accessory respiratory muscles, and barrel chest or any signs of thoracic deformities. 
Respiratory impairment may be assessed by observing the patient’s capability to 
walk the stairs without difficulty, or blowing out a match with his lips open. 
However, it is provided that a pulmonary function test or PFT as well as arterial 
blood gases can provide more accurate respiratory functions and standards for 
measuring the latter (United States Veterans Health Services and Research 
Administration, 1990). 
 Dental treatment requires that the patient has adequate respiratory capacity 
to make sure that the airway is made safe during the treatment process. The use of 
nitrous oxide/ oxygen analgesia is advised against for those with severe COPD, thus 
it is imperative to observe current standard of care which basically involves formal 
PFT and arterial blood gas tests. This will aid the assessment of possible risks which 
may arise during sedation. When patients suffer from moderately severe or severe 
obstruction on PFTs and CO2, patients are advised to undergo pulmonary 
consultation. But in case of mild COPD, patients only suffer from dyspnea on 
significant exertion, hence dental care requires no significant changes in delivery. 
 
39 
On the other hand, patients with moderate COPD will show signs of moderate 
airflow obstruction during pulmonary function testing, some degree of dyspnea on 
exertion, and hypoxia. Using sedatives or respiratory depressants is discouraged as 
they are dangerous, while bronchodilators may have cardiac stimulatory side 
effects. Other drugs which have contraindication are methylxanthines which may 
cause tachycardia, arrythmias, agitated behavior, etc. Meanwhile, severe COPD cases 
are known to experience CO2 retention and dyspnea even while at rest, including 
signs of right heart failure. Many patients under this classification should only 
receive minimal dental intervention until the severity of airflow obstruction 
stabilizes (United States Veterans Health Services and Research Administration, 
1990). 
 The guidelines provided stress the importance of safe treatment among 
dental patients suffering from COPD, especially since the complexity of the process 
lies on the severity and corresponding treatment modalities of the disease. For 
instance, when considering the administration of sedation and/ or general 
anesthesia to COPD patients, especially those that are outside hospital settings, it is 
important to conduct a comprehensive inquiry into the patient’s presentation and 
realistic development of planned treatment, as these are crucial in determining how 
they can tolerate their respiratory condition (Chino, Ganzberg & Mendoza, 2019). 
 Modifying treatment plans is imperative when it comes to progressive 
diseases like COPD. Since patients are constantly at risk of developing pneumonia, 
dental care and special attention must always be present. As previously mentioned, 
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certain procedures may need to be avoided if they limit the patient’s breathing or 
lead to development of cardiovascular strain, hence raising more caution to possible 
complications like oral infections and periodontal disease (Table 3) 






















































Barron, Yamamoto and Iijima (2004) also mentioned smoking cessation as 
an important treatment plan for COPD management which slows down pulmonary 
damages. Aside from being effective and cost effective, smoking cessation also 
decreases the rate of smoking habits within a three-minute period once advised by 
dental practitioners. This form of treatment not only includes an active scientific 
approach for behavioral therapy, but pharmacological techniques as well. 
Dental practitioners would also develop education programs for COPD 
patients where the primary step consists of a description of the disease, particularly 
the way it impacts the structure and function of the lungs. This is also accompanied 
by a corresponding explanation about the dynamics of the respiratory disease 
affecting each patient. Next is on the importance of smoking cessation and the need 
to be mindful of environmental factors such as the effect of passive smoking to one’s 
health. This is followed by a guidance to pharmacological treatment and the possible 
contraindications of certain drugs. With this information, both dentist and patient 
will avoid the risk of unwanted side-effects through suitable methods, frequency 
and times of taking medicine or inhalations (Barron, Yamamoto & Iijima, 2004). 
Dealing with Co-Morbidities (COPD and Oral Diseases) 
 Dental treatment of COPD patients becomes even more complicated with the 
co-existence of two or more related medical conditions, such as advanced age and 
potential significant cardiovascular compromise. Procedures like sedation or 
general anesthesia would need a suitable treatment plan in order to deal with issues 
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like multiple organ systems and risks of precipitating acute respiratory failure 
resulting from inadequate pain and/or anxiety control. As already mentioned, it is 
critical to first find out whether the patient is fit for dental or oral surgery with or 
without sedation/general anesthesia in the office setting, along with appropriate 
monitoring (Chino, Ganzberg & Mendoza, 2019). 
 In a study involving 15,792 selected participants aging 45 to 64 years in the 
Atherosclerosis Risk in Communities or ARIC, Barros et al. (2013) discussed clinical 
implications of other co-morbidities like edentulism (cases where individuals have 
no natural teeth or implants), periodontal disease and systemic biomarkers of 
inflammation. Data has revealed that along with these conditions are the occurrence 
of COPD-related events which consisted mainly of hospitalization due to COPD 
exacerbation. Edentulism, in particular, is said to be predictive of COPD-related 
events since 97% of the study participants are using dentures which are known as 
dwelling places of complex types bacteria, yeasts and fungus that cause the 
inflammation from the oral tissues.  
 This characterization of bacteria shows the complex nature of the microbial 
flora that is present in denture biofilm, where more than 900 individual species of 
aerobic and anaerobic bacteria, yeasts and amoebae are breeding. More 
complexities of such microbial content are also present in denture plaque, and the 
field of dentistry is convinced that unlike the dental biofilm, the biofilm that forms 
on denture materials holds a much larger number of yeasts. Furthermore, candida 
yeasts, specifically Candida albicans, have demonstrated strong pathogenic 
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associations with the presence of denture stomatitis, or the inflammation of the 
mucous membrane of the mouth due to the prolonged use of dentures (Barros et al., 
2013). 
 The same patient risk also occurs in periodontal disease which leads to major 
tooth loss as an inflammatory response to infection which is likely the cause of 
infections on dentures. In addition to this, the ARIC study also showed participants 
who lost their teeth due to periodontal disease and have an inflammatory response 
to the pathogens or fungus are possibly hyper-inflammatory responders. This is 
dangerous because aside from causing more vulnerability to COPD-related events, 
some cases may also lead to death. The decrease in most bacteria from periodontal 
disease is anticipated after the procedure of full mouth tooth extraction. This may 
result to lesser systemic levels of inflammation from periodontal infections, but the 
consequence may also be an increased overall risk for COPD-related events 
following denture biofilm accumulation among the edentulous population. This once 
again supports the information that poor oral health is an important issue in the 
dentistry field, and by understanding its relation with the potential reduction COPD 
incidence, it would be easier for dental practitioners to come up with suitable 
treatment plans (Barros et al., 2013). 
 But according to Baldomero et al. (2019), oral health status has no 
connection with COPD exacerbation which is merely associated with patient-
reported respiratory health status, hence requiring more studies on this subject 
which will prove if oral health considerations will help come up with a potential 
 
44 
method that will improve the respiratory health of patients with COPD. Findings 
were drawn from a case-control study of oral health among COPD exacerbators and 
non-exacerbators. Along with this is the performance of blinded dental exams to 
determine bleeding that is based on probing, probing depth, clinical attachment loss, 
periodontitis severity, plaque index, gingival index, and carries risk. Furthermore, 
logistic regression and linear regression were used to assess the relationships 
between oral health and questionnaires regarding history of COPD exacerbations, 
inhaler use, dental symptoms, dental care habits, etc. 
 However, it did reveal findings regarding trends that showed how more 
severe COPD exacerbations often need emergency room visits and/or 
hospitalizations, especially those involving worse periodontal health indices. This is 
considered as a solid positive correlation between periodontal disease and 
frequency of emergency room visits and hospitalizations for COPD exacerbation. 
Once again, the presence of oral microbiota and oral inflammation are considered as 
important key elements in identifying the relationship between dentition status and 
COPD exacerbations. This confirms the earlier discussion on the role of biofilm 
formation which, if drawn out into the lungs, will lead to the worsening of COPD 
(Baldomero et al., 2019). 
 According to Stahl, Meskin and Brown (2004), the connection between COPD 
and periodontitis (shown by similar disease mechanisms like dysfunctional 
neutrophil behaviors, sustained neutrophilic inflammation, and connective tissue 
loss) increases the possibility that the treatment of one could affect the severity and 
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progression of the other. That is why dental practitioners carry the responsibility of 
educating patients on the impact of poor dental hygiene. Those with low 
socioeconomic status are most in need of instructing regarding proper dental habits 
(e.g. smoking cessation, brushing frequency), along with proper awareness on the 
negative impacts of one’s poor self-care behaviors and exposure to environmental 
factors like pollutants. 
Occupational exposure also plays a critical role in assessing the severity of 
COPD, where information regarding patient history is drawn through inquiries 
regarding one being subjected to dust, gases, fumes, and other harmful elements. 
These apparently contribute to the rapid decline of one’s health, as well as the 
increased prevalence of chronic bronchitis. By reviewing the patient’s occupational 
history, dentists gain access to the best clinical tool of assessment. Other factors for 
consideration are exposure duration, intensity, the year the job began and ended, 
and the frequency of one’s exposure to these harmful elements for acquiring an 
approximation on the intensity of exposure (Barnes et al., 2009). 
But patient exposure only becomes relevant information once it is 
determined through a number of years and decades. Aside from this, irregular work 
environments like spending time in the armed forces, imprisonment, etc. may also 
be considered as contributing factors to COPD. Asking patients for this information 
is considered as reliable, including patient observation regarding any noticeable 
dust, fumes or gas within the totality of working conditions. Dentists and other 
clinicians are advised against complacency when analyzing workplace exposure that 
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are deemed within safe limits as this does not mean that one cannot contract the 
disease. In fact, studies showed how some patients suffer from significant airflow 
obstruction after being subject to regulated allowable limits (Barnes et al., 2009). 
COPD and its components, chronic bronchitis and emphysema, are not 
curative. Dentists and patients rely on smoking cessation as a primary 
recommendation to those who are identified to be suffering from this ailment. It is 
also important to maintain regular exercise, proper nutrition, and aggressive 
treatment of respiratory infections to help with the patient’s everyday functioning 
while dealing with this debilitating disease. Furthermore, it must be remembered 
that COPD patients are often low in oxygen supply, hence incapable of filling the 
necessary minimum level of oxygenation (Henshaw & Singhal, 2017). Also referred 
to as hypoxemia, this major complication is a risk that may also occur among 
sedated dental patients. Mueller et al. (1985) studied the case of pediatric dental 
patients who often resort to outpatient sedation as treatment when the child is 
unable to receive nonpharmacological means. Monitoring is required in case early 
signs of hypoxemia is detected and, therefore, be corrected. 
The use of pulse oximetry is considered an accurate, continuous, and non-
invasive technology in monitoring the oxygen status of sedated dental patients. 
While conventional approaches are also useful, pulse oximetry offers a greater 
safety margin (Henshaw & Singhal, 2017). An additional perspective was also given 
by Henshaw and Singhal (2017) when it comes to COPD and smoking. They stated 
that albeit smoking often causes COPD, an estimated 20% of the 9.5 million people 
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are non-smokers. The nature or dynamics of the disease has more to do with the 
blockage that leads to the constriction of small airways. Other complications include 
increase in sputum production, mucus plugging, and the failed functioning of 
peripheral airways. Patients with chronic bronchitis tend to have excessive mucus 
production and chronic cough with sputum production which could last for at least 
3 months. On the other hand, those who are afflicted by emphysema are affected by 
the damage in alveolar epithelium. This is even aggravated by smoking which leads 



















 Chronic Obstructive Pulmonary Disorder is between third and fourth leading 
cause of death, and this is within the United States alone. This progressive and 
debilitating disease affects the quality of life of individuals afflicted which is why the 
healthcare system is doing its best to come up with effective treatment options. 
Within the health system the field of dentistry aims to meet the needs of dental 
patients with COPD. The impact of COPD among dental practitioners is critical 
especially when it comes to management. The needs of dental patients must always 
be a priority and dentists must learn to adjust from making sure that they have a 
relaxed atmosphere, to providing effective dental treatments while prescribing the 
most suitable medications to allow safe treatment even as COPD progresses. The 
status of dentistry in terms of COPD management remains a work in progress, and 
the primary task of dental practitioners is to educate their patients on CODP 
prevention mainly through oral hygiene and smoking cessation. But certain 
breakthroughs have already been achieved by the dental field, such as identifying 
certain roles of the immune system that will help predict even more the nature and 
dynamics of COPD that will hopefully lead to effective treatments and therapeutic 
targets. Furthermore, the field of dentistry continues to strives to provide up-to-
date guidelines that will enhance awareness among both patients and dental 
practitioners in order to continue to provide quality and up-to-date care with the 
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